| Registration status | Registration Changed to AVIDITY PARTNERS MANAGEMENT LP |
|
Exempt Reporting Adviser
2B(3)- PF>150mn
act solely as an adviser to private funds but you are no longer eligible to check box 2.B.(2) because you have assets under management, as defined in rule 203(m)-1, in the United States of $150 million or more |
|
| Private Fund GAV* | 0 |
| SMA’s | No |
| Private Funds | 0 1 |
| Contact Info | 214 xxxxxxx |
| Stock Ticker | Stock Name | $ Position | % Position | $ Change | # Change |
|---|---|---|---|---|---|
| Stck Ticker252828108 | Stock NameDIANTHUS THERAPEUTICS INC | $ Position$86,713,423 | % Position25.00% | $ Change-31.00% | # Change-34.00% |
| Stck Ticker156944100 | Stock NameCG ONCOLOGY INC | $ Position$61,146,462 | % Position18.00% | $ Change-5.00% | # Change-8.00% |
| Stck Ticker008064206 | Stock NameJADE BIOSCIENCES INC | $ Position$21,612,924 | % Position6.00% | $ Change122.00% | # Change24.00% |
| Stck Ticker687604108 | Stock NameORUKA THERAPEUTICS INC | $ Position$20,017,451 | % Position6.00% | $ Change58.00% | # Change0.00% |
| Stck Ticker881624209 | Stock NameTEVA PHARMACEUTICAL INDS LTD | $ Position$13,023,933 | % Position4.00% | $ Change26.00% | # Change-18.00% |
| Stck Ticker46489V302 | Stock NamePERSPECTIVE THERAPEUTICS INC | $ Position$8,829,516 | % Position3.00% | $ Change-14.00% | # Change7.00% |
| Stck TickerG5960L103 | Stock NameMEDTRONIC PLC | $ Position$10,336,056 | % Position3.00% | $ Change-43.00% | # Change-44.00% |
| Stck Ticker101137107 | Stock NameBOSTON SCIENTIFIC CORP | $ Position$10,917,575 | % Position3.00% | $ Change-32.00% | # Change-30.00% |
| Stck Ticker21077P108 | Stock NameCONTEXT THERAPEUTICS INC | $ Position$8,092,137 | % Position2.00% | $ Change-7.00% | # Change-39.00% |
| Stck Ticker00846U101 | Stock NameAGILENT TECHNOLOGIES INC | $ Position$5,646,905 | % Position2.00% | $ Change | # Change |